The Enterprise Value as of November 2024 (TTM) for Adverum Biotechnologies, Inc. (ADVM) is 106.06M

According to Adverum Biotechnologies, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 106.06M. This represents a change of -5.49% compared to the average of 112.22M of the last 4 quarters.

Adverum Biotechnologies, Inc. (ADVM) Historical Enterprise Value (quarterly & annually)

How has ADVM Enterprise Value performed in the past?

The mean historical Enterprise Value of Adverum Biotechnologies, Inc. over the last ten years is 2.04B. The current 106.06M Enterprise Value has changed 420.68% with respect to the historical average. Over the past ten years (40 quarters), ADVM's Enterprise Value was at its highest in in the June 2020 quarter at 16.76B. The Enterprise Value was at its lowest in in the December 2023 quarter at 76.25M.

Adverum Biotechnologies, Inc. (ADVM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Adverum Biotechnologies, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Adverum Biotechnologies, Inc. (ADVM) Average Enterprise Value

How has ADVM Enterprise Value performed in the past?

The current Enterprise Value of Adverum Biotechnologies, Inc. (ADVM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Adverum Biotechnologies, Inc. (ADVM) Enterprise Value vs. Peers

How is ADVM’s Enterprise Value compared to its peers?

Adverum Biotechnologies, Inc.’s Enterprise Value is greater than uniQure N.V. (97.71M), less than Rocket Pharmaceuticals, Inc. (1.25B), less than Rhythm Pharmaceuticals, Inc. (3.64B), less than Solid Biosciences Inc. (176.48M), less than MeiraGTx Holdings plc (427.31M), greater than Aerovate Therapeutics, Inc. (46.23M), greater than Adagene Inc. (22.22M), less than Acrivon Therapeutics, Inc. Common Stock (163.47M), less than Rezolute, Inc. (276.11M), greater than AN2 Therapeutics, Inc. (6.48M), greater than Passage Bio, Inc. (24.72M), less than Absci Corporation (267.83M), greater than Kezar Life Sciences, Inc. (36.78M), greater than Oncternal Therapeutics, Inc. (-9513999.00), less than Kodiak Sciences Inc. (201.31M), greater than Galmed Pharmaceuticals Ltd. (-5167277.00), greater than Affimed N.V. (43.76M), less than Mereo BioPharma Group plc (496.22M), greater than Homology Medicines, Inc. (-103303255.00), less than Stoke Therapeutics, Inc. (457.69M), greater than Atreca, Inc. (-8620212.00), greater than TCR2 Therapeutics Inc. (79.12M),

Build a custom stock screener for Adverum Biotechnologies, Inc. (ADVM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adverum Biotechnologies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Adverum Biotechnologies, Inc. (ADVM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Adverum Biotechnologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.